SIRT1 and glomerulosclerosis: SRT3025 also activates Sirt1 and has been reported to reverse the increase in collagen production due to TGF-β1 stimulation, reduce glomerulosclerosis and tubulointerstitial fibrosis, and attenuate the decrease in the glomerular filtration rate and proteinuria [179].